researcher comment: the fraction-rcc study | toni choueiri
Published 4 years ago • 166 plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
4:24
researcher comment: the savoir trial | toni choueiri
-
2:37
researcher comment: hif-2α inhibition in rcc | toni chouieri
-
2:16
researcher comment: the radvax rcc study | hans hammers
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
2:53
cosmic-313 points to first-line triplet option for advanced rcc | toni choueiri
-
3:41
a physician faces stage iv #kidneycancer: his advice for you
-
4:12
acinic cell carcinoma fna cytology
-
5:11
thyroid fna cytology - medullary thyroid carcinoma
-
4:58
researcher comment: the keynote-146/study 111 trial | chung-han lee
-
4:53
researcher comment: sitravatinib plus nivolumab in advanced rcc | pavlos msaouel
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
1:42
dana-farber cancer institute: toni k. choueiri, md (kidney cancer research at asco gu21)
-
3:16
researcher comment: the blasst-1 trial | shilpa gupta
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc
-
1:08
kidney cancer expert dr. toni choueiri: the 2022 kidney cancer research summit by kidneycan
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
0:38
cancer research, best of 2010s: toni choueiri, md
-
1:41
dr. choueiri on next steps for treatment in rcc
-
2:01
esmo22: toni choueiri, md | dana-farber cancer institute
-
3:07
pembrolizumab, sabr develop a rapport for oligometastatic rcc | shankar siva
-
4:14
molecular determinants of ici response in sarcomatoid and rhabdoid rcc | ziad bakouny
-
1:50
asco22: kidney cancer research by toni choueiri, md | dana-farber cancer institute